The Arab Drug Company (EGX:ADCI)

Egypt flag Egypt · Delayed Price · Currency is EGP
154.72
-3.37 (-2.13%)
At close: Feb 26, 2026
118.70%
Market Cap 1.86B
Revenue (ttm) 1.19B
Net Income (ttm) 222.05M
Shares Out 12.00M
EPS (ttm) 18.50
PE Ratio 8.36
Forward PE n/a
Dividend 4.17 (2.69%)
Ex-Dividend Date Oct 28, 2025
Volume 21,220
Average Volume 21,795
Open 158.09
Previous Close 158.09
Day's Range 154.00 - 159.99
52-Week Range 69.00 - 249.98
Beta 0.34
RSI 30.36
Earnings Date Feb 12, 2026

About The Arab Drug Company

The Arab Drug Company engages in the manufacture and sale of pharmaceutical products. It offers anti-infectives, central nervous system drugs, dermatological drugs, and cardiovascular drugs, as well as animal health products in powders and solutions. The company exports its products to approximately 40 countries, including China, Korea, Turkey, Kazakhstan, Iraq, Syria, Jordan, Lebanon, Libya, Sudan, Somalia, Yemen, and Morocco. The Arab Drug Company was incorporated in 1963 and is based in Cairo, Egypt. [Read more]

Industry Pharmaceutical Preparations
Founded 1963
Employees 1,148
Stock Exchange Egyptian Stock Exchange
Ticker Symbol ADCI
Full Company Profile

Financial Performance

In fiscal year 2025, The Arab Drug Company's revenue was 1.12 billion, an increase of 42.35% compared to the previous year's 785.52 million. Earnings were 198.93 million, an increase of 125.18%.

Financial Statements

News

There is no news available yet.